symptomatic

New data from Britain suggests that booster protection against symptomatic Covid caused by the Omicron variant wanes within 10 weeks.There have not yet been enough severe cases of Omicron to…

MIAMI, Dec. 23, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) announces preliminary topline results from its Phase 2 trial with RAYALDEE® to treat mild-to-moderate COVID-19.…

The U.S. Food and Drug Administration authorized a preventive antibody combination from AstraZeneca AZN 0.68% PLC that has shown strong…

Covaxin is a Vero cell-derived, inactivated whole-virion vaccine formulated with a novel adjuvantBharat Biotech’s Covaxin is 50 per cent effective as a vaccine against symptomatic Covid-19…

By PTI NEW DELHI: Two doses of Covaxin are 50 per cent effective against symptomatic COVID-19, according to the first real-world assessment of India's indigenous…

Researchers noted that the Delta variant was the dominant strain in India during the study period, accounting for approximately 80 per cent of all confirmed COVID-19 cases. (PTI…

Progranulin Levels Increase to Normal Ranges Multiple Biomarkers of Disease Showed Improvement from Baseline with AL001 Treatment, Including GFAP, a Prognostic Marker for FTD Associated…

World Health Organization approved Covaxin for use among people aged 18 years and aboveBharat Biotech’s Covaxin demonstrates 77.8 per cent efficacy against symptomatic Covid-19,…

in 26%, chills in 16%, muscle pain in 16%, and chest pain in 10%. "Given the evolving nature of COVID-19, it is critical for hospitals to…

COVID-19 vaccines are highly effective in preventing symptomatic illness among health care workers in real-world settings. The study, published in the New England Journal of Medicine, found…